REDHILL BIOPHARMA LTD. Number Of Share Options Exercisable In Share-based Payment Arrangement
REDHILL BIOPHARMA LTD. (RDHL) had Number Of Share Options Exercisable In Share-based Payment Arrangement of 2.52 thousand Option as of 2024-12-31, per its 20-F filed 2025-04-10.
Financial Statements › Notes › Compensation Related Costs
ifrs-full:NumberOfShareOptionsExercisableInSharebasedPaymentArrangement · last filed 2025-04-10
- 2024-12-31: Number Of Share Options Exercisable In Share-based Payment Arrangement 2.52K Option.
- 2023-12-31: Number Of Share Options Exercisable In Share-based Payment Arrangement 3.46K Option; Number Of Share Options Exercisable In Share-based Payment Arrangement as first filed 86.37K Option.
- 2022-12-31: Number Of Share Options Exercisable In Share-based Payment Arrangement 98.76K Option; Number Of Share Options Exercisable In Share-based Payment Arrangement as first filed 3.95M Option.
- 2021-12-31: Number Of Share Options Exercisable In Share-based Payment Arrangement 3.62M Option.
| Period end | Number Of Share Options Exercisable In Share-based Payment Arrangement | Number Of Share Options Exercisable In Share-based Payment Arrangement as first filed |
|---|---|---|
| 2024-12-31 | 2.52K Option 20-F · filed 2025-04-10 | |
| 2023-12-31 | 3.46K Option 20-F · filed 2025-04-10 | 86.37K Option 20-F · filed 2024-04-08 |
| 2022-12-31 | 98.76K Option 20-F · filed 2024-04-08 | 3.95M Option 20-F · filed 2023-04-28 |
| 2021-12-31 | 3.62M Option 20-F · filed 2023-04-28 | |
| 2020-12-31 | 3.18M Option 20-F · filed 2022-03-17 | |
| 2019-12-31 | 2.49M Option 20-F · filed 2021-03-18 | 24.90M Option 20-F · filed 2020-03-04 |
| 2018-12-31 | 12.96M Option 20-F · filed 2020-03-04 | |
| 2017-12-31 | 16.84M Option 20-F · filed 2019-02-26 | |
| 2016-12-31 | 15.17M Option 20-F · filed 2018-02-22 |